VISEN Pharmaceuticals_Emerging Expert in Endocrinology
VISEN is an innovative biopharmaceutical company focused on endocrine diseases. We are committed to providing innovative therapies and compassionate, patient-centric care, because we believe that achieving better treatment processes and outcomes results in living better lives.
Visen
Visen Industries Limited, a leading manufacturer of polymer emulsions, centres its efforts on delivering premium products to paint, textile, adhesive and construction industries as well as consumer products.
VISEN Pharmaceuticals Closes $150 Million Series B Financing ...
SHANGHAI, Jan. 9, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for ...
VISENPharmaceuticals_CompanyOverview
VISEN is an innovative biopharmaceutical company focused on endocrine diseases. We are dedicated to providing innovative therapies and compassionate, patient-centric care, because we believe that achieving better treatment processes and outcomes results in living better lives.
VISEN Pharmaceuticals announced that the Phase 3 PaTHway ...
2024年8月12日 · VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, today announced topline data from the 26-week randomized, double-blind, placebo-controlled portion of...
Ascendis Pharma A/S Announces Equity Investment in VISEN ...
VISEN Pharmaceuticals is committed to the treatment of endocrine-related diseases, introducing the world’s leading treatment methods and drugs into the China market and hoping to provide more Chinese patients quick access to the world's most advanced and …
VISEN Pharmaceuticals Announces Top-line Results of Phase 3 ...
2022年5月23日 · VISEN Pharmaceuticals Announces Top-line Results of Phase 3 Trial of Once-Weekly Lonapegsomatropin, Demonstrating Superior Efficacy, Comparable Safety and Tolerability to Daily Growth Hormone.